N/A
N=135
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
Medical; Abortion, Fetus
Bottom Line
View on ClinicalTrials.gov: NCT02694198 ↗Enrolled (actual)
135
Serious AEs
0.0%
Results posted
Apr 2016
Primary outcome: Primary: Cervicovaginal Fetal Fibronectin Level — 39.4 nanogram per milliliter
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- fetal fibronectin measurement (Other)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Ain Shams Maternity Hospital
- Primary completion
- Mar 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cervicovaginal Fetal Fibronectin Level |
39.4 | — |
| PRIMARY Relation of Cervicovaginal Fetal Fibronectin Level to Duration of Induction of Abortion |
39.3; 40.4 | — |
Summary
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester abortion.
Eligibility Criteria
Inclusion Criteria
- Singleton pregnancy.
- 14-24 weeks gestation..
- Missed miscarriage
Exclusion Criteria
- History of pulmonary, hepatic, renal, or cardiovascular diseases.
- History of previous cesarean section and other uterine surgeries as hysterotomy and myomectomy.
- Inevitable abortion.
- Placenta covering internal os.
- History of any cervical surgery as cervical amputation, cauterization or dilatation.
- Premature rupture of membranes.
- Any vaginal bleeding.
- Contraindications for misoprostol as hypersensitivity to misoprostol, chronic adrenal insufficiency and inherited porphyrias.
Data sourced from ClinicalTrials.gov (NCT02694198). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.